The most frequently reported NAEs included dizziness (n = 7,078), tremor (n = 2,519), dysgeusia (n = 1,469), lethargy (n = 783), taste disorder (n = 482), presyncope (n = 370), allodynia (n = 192), and parosmia (n = 192) (Fig
Retatrutide (Eli Lilly and Company, Indianapolis, IN, USA) is currently in phase 3 of clinical trials (TRIUMPH programme), where its antiobesity effect is being compared with placebo (NCT06383390 and NCT05929066) and with tirzepatide (NCT06662383)
No significant differences were found in basal BMI or waist circumference values between subjects improving or not improving HbA1c in any of the groups (PLC or MO)
Look for a product that has a more biologically active form, like 10% L-ascorbic acid, so that it can get to work on your face right away
If pharmacological intervention is deemed appropriate, referral to specialist services such as tier 3 weight management programmes or bariatric medicine clinics may be necessary